Dr. Hadiyah-Nicole Green, an accomplished multi-disciplinary physicist and the second African American woman to receive a Ph.D. in physics from the University of Alabama at Birmingham, has achieved a historic milestone by being the first to successfully treat cancer using laser-activated nanoparticles.
As reported by Black Culture News, Dr. Green was awarded a $1.1 million grant to further her groundbreaking research in nanoparticle cancer treatment.
As the visionary founder of the Ora Lee Smith Cancer Research Foundation, Dr. Green's cutting-edge nanoparticle technology offers a revolutionary approach that spares patients from chemotherapy, radiation, or surgery. Remarkably, this treatment successfully eradicated cancer in mice within just 15 days.
Dr. Green's dedication to cancer treatment was ignited by the tragic loss of her aunt, Ora Lee, to cancer, as well as witnessing her uncle, General Lee Smith, endure the harsh side effects of conventional chemotherapy.
Driven by her determination to find more effective cancer treatments, Dr. Green pursued her bachelor's degree in physics and optics at Alabama A&M University, followed by a Master of Science in physics at the University of Alabama at Birmingham, receiving full scholarships for both programs.
Subsequently, she contributed her expertise to the Comprehensive Cancer Center for five years and the Department of Pathology for one year.
Upon completing her graduate studies, Dr. Green served as an assistant professor at Tuskegee University's Department of Material Science and Engineering, and later joined Morehouse School of Medicine's Physiology Department in the same capacity.
Today, the Ora Lee Smith Research Foundation continues its unwavering mission to combat cancer using laser-activated nanoparticles, striving to make cancer treatment accessible, affordable, and effective. Dr. Green also generously dedicates her time to mentoring young Black students.
Thank you to Dr. Hadiyah-Nicole Green for her unwavering commitment to medical research and the advancement of cancer treatment.